How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials

For access to the full issue, click here.

About the Author

Jill Platko

Dr. Jill V. Platko is a Senior Scientific Advisor at CRF Health. She has over 16 years of experience in biology-based scientific research and has led projects for renowned institutions such as: Cornell University, Genome Therapeutics Corporation, Whitehead Institute Center for Genome Research, & Massachusetts General Hospital. Dr. Platko completed her PhD in Genetics and Development at Cornell University, and she received a BS in Biology from the State University of New York at Albany.

More Content by Jill Platko
Previous
eCOA Design Considerations: Reminders and Alarms
eCOA Design Considerations: Reminders and Alarms

Dr. Jill Platko discusses why reminders and alarms are important for the simplest and most complex clinical...

Next
Understanding the Benefits of eCOA in Oncology Clinical Trials
Understanding the Benefits of eCOA in Oncology Clinical Trials

Dan Limbach of PharmaVOICE interviews CRF Health's Katie Garner, Therapeutic Areas Manager, about the benef...